PreprintAll rights reservedmedRxiv
Saccharomyces boulardii as Adjunctive Therapy in Helicobacter pylori Eradication: A Randomized, Placebo-Controlled Trial.
- 1Isfahan University of Medical Siences
Related
- Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
- Anaprazole-based versus rabeprazole-based quadruple therapy for Helicobacter pylori eradication: a prospective, multicenter, randomized controlled trial.
- Adjunctive probiotics may reduce adverse events during vonoprazan-based Helicobacter pylori eradication: a systematic review and meta-analysis
- Adjunctive Oral Treatment Improves Helicobacter pylori Eradication Without Evidence of a Dose-Response Gradient: An Updated Meta-Analysis Challenging the Oral Reservoir Hypothesis
- Helicobacter pylori eradication for immune thrombocytopenia reduces non-response and raises platelet counts: Meta-analysis of randomized trials.
BibTeX
@misc{jafari2026saccharomyces,
title = {{Saccharomyces boulardii as Adjunctive Therapy in Helicobacter pylori Eradication: A Randomized, Placebo-Controlled Trial.}},
author = {M. Jafari and N. Moradi and H. Abdolahi and F. Keshaei},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.09.26367596},
url = {https://www.medrxiv.org/content/10.64898/2026.11.09.26367596v1},
}
RIS
TY - UNPB
TI - Saccharomyces boulardii as Adjunctive Therapy in Helicobacter pylori Eradication: A Randomized, Placebo-Controlled Trial.
AU - M. Jafari
AU - N. Moradi
AU - H. Abdolahi
AU - F. Keshaei
PY - 2026
DA - 2026/11/09
PB - medRxiv
DO - 10.64898/2026.11.09.26367596
UR - https://www.medrxiv.org/content/10.64898/2026.11.09.26367596v1
ER -